Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Heuser

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Journal of the Neurological Sciences|July 25, 2006
Cerebrovascular reactivity over time course in healthy subjectsN Schwertfeger, P Neu, P Schlattmann, et al.
Psychiatry Research|October 1, 1989
Diagnostic determinants of response to treatment with tricyclic antidepressants: a polydiagnostic approachW Maier, M Philipp, S Schlegel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patientsI Heuser, M Deuschle, P Luppa, et al.
Dementia and Geriatric Cognitive Disorders|February 10, 2011
Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluidC G Schipke, S Prokop, F L Heppner, et al.
Neuroendocrinology|November 21, 1998
Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humansM Deuschle, B Weber, M Colla, et al.
Neuropsychobiology|February 15, 2001
The glutamate antagonist riluzole and its effects upon basal and stress-induced activity of the human hypothalamus-pituitary-adrenocortical system in elderly subjectsA Kniest, C Wiesenberg, B Weber, et al.
Pharmacopsychiatry|November 25, 2006
The effect of donepezil on sleep in elderly, healthy persons: a double-blind placebo-controlled studyM Schredl, O Hornung, F Regen, et al.
Pharmacopsychiatry|February 12, 2005
Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challengesG Kronenberg, P Berger, R F Tauber, et al.
The Journal of Clinical Psychiatry|March 15, 2001
Antidepressant treatment and global tests of coagulation and fibrinolysisF Lederbogen, B Weber, M Colla, et al.
The American Journal of Physiology|April 1, 1995
Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depressionU Gotthardt, U Schweiger, J Fahrenberg, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Journal of the Neurological Sciences|July 25, 2006
Cerebrovascular reactivity over time course in healthy subjectsN Schwertfeger, P Neu, P Schlattmann, et al.
Psychiatry Research|October 1, 1989
Diagnostic determinants of response to treatment with tricyclic antidepressants: a polydiagnostic approachW Maier, M Philipp, S Schlegel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patientsI Heuser, M Deuschle, P Luppa, et al.
Dementia and Geriatric Cognitive Disorders|February 10, 2011
Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluidC G Schipke, S Prokop, F L Heppner, et al.
Neuroendocrinology|November 21, 1998
Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humansM Deuschle, B Weber, M Colla, et al.
Neuropsychobiology|February 15, 2001
The glutamate antagonist riluzole and its effects upon basal and stress-induced activity of the human hypothalamus-pituitary-adrenocortical system in elderly subjectsA Kniest, C Wiesenberg, B Weber, et al.
Pharmacopsychiatry|November 25, 2006
The effect of donepezil on sleep in elderly, healthy persons: a double-blind placebo-controlled studyM Schredl, O Hornung, F Regen, et al.
Pharmacopsychiatry|February 12, 2005
Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challengesG Kronenberg, P Berger, R F Tauber, et al.
The Journal of Clinical Psychiatry|March 15, 2001
Antidepressant treatment and global tests of coagulation and fibrinolysisF Lederbogen, B Weber, M Colla, et al.
The American Journal of Physiology|April 1, 1995
Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depressionU Gotthardt, U Schweiger, J Fahrenberg, et al.
Pageof 12